Loss of response after first-line biologic therapy in patients with inflammatory bowel disease: practical approach and management

被引：0
|
作者：
Busacca, A. [1 ]
Scrivo, B. [1 ]
Giuffrida, E. [1 ]
Guida, L. [1 ]
Carrozza, L. [1 ]
Calvaruso, V. [1 ]
Cappello, M. [1 ]
机构：
[1] Univ Palermo, Gastroenterol & Hepatol Sect, PROMISE, Palermo, Italy
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P293
引用
收藏
页码：S299 / S299
页数：1
相关论文
共 50 条
  • [31] Hormone therapy for first-line management of menopausal symptoms: Practical recommendations
    Palacios, Santiago
    Stevenson, John C.
    Schaudig, Katrin
    Lukasiewicz, Monika
    Graziottin, Alessandra
    WOMENS HEALTH, 2019, 15
  • [32] INFECTIOUS COMPLICATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECIEVING BIOLOGIC THERAPY
    Ochoa, C. D.
    Rajaram, P.
    Tanukonda, S.
    Sadikot, R. T.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2016, 64 (02) : 679 - 680
  • [33] Management of Biologic Agents During Pregnancy in Patients with Inflammatory Bowel Disease
    Sheibani, Sarah
    Mahadevan, Uma
    PRACTICAL GASTROENTEROLOGY, 2013, 37 (06) : 34 - +
  • [34] Challenges in the Management of and Biologic Use in Incarcerated Patients With Inflammatory Bowel Disease
    Barbina, Sarah
    Romano, John
    Forster, Erin
    CROHNS & COLITIS 360, 2023, 5 (02)
  • [35] Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease
    Shmidt, Eugenia
    Kochhar, Gursimran
    Hartke, Justin
    Chilukuri, Prianka
    Meserve, Joseph
    Chaudrey, Khadija
    Koliani-Pace, Jenna L.
    Hirten, Robert
    Faleck, David
    Barocas, Morris
    Luo, Michelle
    Lasch, Karen
    Boland, Brigid S.
    Singh, Siddharth
    Vande Casteele, Niels
    Sagi, Sashidhar Varma
    Fischer, Monika
    Chang, Shannon
    Bohm, Matthew
    Lukin, Dana
    Sultan, Keith
    Swaminath, Arun
    Hudesman, David
    Gupta, Nitin
    Kane, Sunanda
    Loftus, Edward V., Jr.
    Sandborn, William J.
    Siegel, Corey A.
    Sands, Bruce E.
    Colombel, Jean-Frederic
    Shen, Bo
    Dulai, Parambir S.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (11) : 2461 - 2467
  • [36] Assessing primary response to biologic therapy in Inflammatory Bowel Disease - 'the when and the how?'
    Moore, A. C.
    Peake, S.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S470 - S470
  • [37] Approach to loss of response to advanced therapies in inflammatory bowel disease
    Vootukuru, Nikil
    Vasudevan, Abhinav
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (22) : 2902 - 2919
  • [38] Management of the Elderly Patients with Inflammatory Bowel Disease: Practical Considerations
    Katz, Seymour
    Surawicz, Christina
    Pardi, Darrell S.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (10) : 2257 - 2272
  • [39] RESPIRATORY INFECTIONS IN PATIENTS UNDERGOING FIRST-LINE BIOLOGIC THERAPY FOR RHEUMATOID ARTHRITIS
    Nakamoto, Keitaro
    Saraya, Takeshi
    Sada, Mitsuru
    Inui, Toshiya
    Ogawa, Yukari
    Koide, Takashi
    Takata, Saori
    Watanabe, Masato
    Yokoyama, Takuma
    Kurai, Daisuke
    Ishii, Haruyuki
    Takizawa, Hajime
    RESPIROLOGY, 2015, 20 : 133 - 133
  • [40] MECHANISMS OF WEIGHT CHANGE AFTER INITIATION OF BIOLOGIC THERAPY FOR INFLAMMATORY BOWEL DISEASE
    Henneberg, Cameron
    McCaughey, Candice
    Chen, Xialing Ann
    O'Laco, Karen Anne
    Kwaning, Karen
    Brewer, Gala Godoy
    Sauk, Jenny S.
    Parian, Alyssa
    Limketkai, Berkeley N.
    GASTROENTEROLOGY, 2021, 160 (06) : S704 - S705
12345